CVE:GSD

Devonian Health Group Competitors

C$0.26
-0.01 (-3.70 %)
(As of 04/16/2021 05:41 PM ET)
Add
Compare
Today's Range
C$0.26
Now: C$0.26
C$0.40
50-Day Range
C$0.15
MA: C$0.23
C$0.28
52-Week Range
C$0.09
Now: C$0.26
C$0.40
Volume131,458 shs
Average Volume38,999 shs
Market CapitalizationC$24.14 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Devonian Health Group (CVE:GSD) Vs. PMN, COV, EMH, IGX, QPT, and CZO

Should you be buying GSD stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Devonian Health Group, including ProMIS Neurosciences (PMN), Covalon Technologies (COV), Emerald Health Therapeutics (EMH), IntelGenx Technologies (IGX), Quest PharmaTech (QPT), and Ceapro (CZO).

Devonian Health Group (CVE:GSD) and ProMIS Neurosciences (TSE:PMN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends.

Valuation and Earnings

This table compares Devonian Health Group and ProMIS Neurosciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Devonian Health GroupC$1.59 million15.20C$-4,457,184.00C($0.05)-5.42
ProMIS NeurosciencesC$1,787.0031,673.61C$-6,119,000.00C($0.02)-9.25

Devonian Health Group has higher revenue and earnings than ProMIS Neurosciences. ProMIS Neurosciences is trading at a lower price-to-earnings ratio than Devonian Health Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Devonian Health Group and ProMIS Neurosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Devonian Health GroupN/AN/AN/A
ProMIS NeurosciencesN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations for Devonian Health Group and ProMIS Neurosciences, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Devonian Health Group0000N/A
ProMIS Neurosciences0000N/A

Summary

Devonian Health Group beats ProMIS Neurosciences on 3 of the 5 factors compared between the two stocks.

Devonian Health Group (CVE:GSD) and Covalon Technologies (CVE:COV) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Devonian Health Group and Covalon Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Devonian Health Group0000N/A
Covalon Technologies0000N/A

Earnings and Valuation

This table compares Devonian Health Group and Covalon Technologies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Devonian Health GroupC$1.59 million15.20C$-4,457,184.00C($0.05)-5.42
Covalon TechnologiesC$23.84 million1.68C$-6,144,922.00C($0.24)-6.51

Devonian Health Group has higher earnings, but lower revenue than Covalon Technologies. Covalon Technologies is trading at a lower price-to-earnings ratio than Devonian Health Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Devonian Health Group and Covalon Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Devonian Health GroupN/AN/AN/A
Covalon TechnologiesN/AN/AN/A

Summary

Devonian Health Group beats Covalon Technologies on 4 of the 5 factors compared between the two stocks.

Emerald Health Therapeutics (CVE:EMH) and Devonian Health Group (CVE:GSD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Earnings & Valuation

This table compares Emerald Health Therapeutics and Devonian Health Group's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Emerald Health TherapeuticsC$13.02 million3.94C$-142,699,488.00C($0.70)-0.36
Devonian Health GroupC$1.59 million15.20C$-4,457,184.00C($0.05)-5.42

Devonian Health Group has lower revenue, but higher earnings than Emerald Health Therapeutics. Devonian Health Group is trading at a lower price-to-earnings ratio than Emerald Health Therapeutics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Emerald Health Therapeutics and Devonian Health Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Emerald Health TherapeuticsN/AN/AN/A
Devonian Health GroupN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for Emerald Health Therapeutics and Devonian Health Group, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Emerald Health Therapeutics0000N/A
Devonian Health Group0000N/A

Summary

Devonian Health Group beats Emerald Health Therapeutics on 3 of the 5 factors compared between the two stocks.

IntelGenx Technologies (CVE:IGX) and Devonian Health Group (CVE:GSD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.

Analyst Recommendations

This is a summary of recent ratings and price targets for IntelGenx Technologies and Devonian Health Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
IntelGenx Technologies0000N/A
Devonian Health Group0000N/A

Earnings and Valuation

This table compares IntelGenx Technologies and Devonian Health Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IntelGenx TechnologiesC$1.54 million38.41C$-9,064,710.00C($0.08)-6.54
Devonian Health GroupC$1.59 million15.20C$-4,457,184.00C($0.05)-5.42

Devonian Health Group has higher revenue and earnings than IntelGenx Technologies. IntelGenx Technologies is trading at a lower price-to-earnings ratio than Devonian Health Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares IntelGenx Technologies and Devonian Health Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
IntelGenx TechnologiesN/AN/AN/A
Devonian Health GroupN/AN/AN/A

Summary

Devonian Health Group beats IntelGenx Technologies on 4 of the 5 factors compared between the two stocks.

Devonian Health Group (CVE:GSD) and Quest PharmaTech (CVE:QPT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Earnings & Valuation

This table compares Devonian Health Group and Quest PharmaTech's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Devonian Health GroupC$1.59 million15.20C$-4,457,184.00C($0.05)-5.42
Quest PharmaTechC$38,871.00453.13C$109.88 millionC$0.660.16

Quest PharmaTech has lower revenue, but higher earnings than Devonian Health Group. Devonian Health Group is trading at a lower price-to-earnings ratio than Quest PharmaTech, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Devonian Health Group and Quest PharmaTech, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Devonian Health Group0000N/A
Quest PharmaTech0000N/A

Profitability

This table compares Devonian Health Group and Quest PharmaTech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Devonian Health GroupN/AN/AN/A
Quest PharmaTechN/AN/AN/A

Summary

Quest PharmaTech beats Devonian Health Group on 4 of the 5 factors compared between the two stocks.

Ceapro (CVE:CZO) and Devonian Health Group (CVE:GSD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

Earnings and Valuation

This table compares Ceapro and Devonian Health Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CeaproC$16.14 million3.56C$2.56 millionC$0.0322.42
Devonian Health GroupC$1.59 million15.20C$-4,457,184.00C($0.05)-5.42

Ceapro has higher revenue and earnings than Devonian Health Group. Devonian Health Group is trading at a lower price-to-earnings ratio than Ceapro, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Ceapro and Devonian Health Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CeaproN/AN/AN/A
Devonian Health GroupN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings for Ceapro and Devonian Health Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ceapro0000N/A
Devonian Health Group0000N/A

Summary

Ceapro beats Devonian Health Group on 4 of the 5 factors compared between the two stocks.


Devonian Health Group Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
PMN
ProMIS Neurosciences
0.5$0.19-2.7%C$55.07 millionC$1,787.00-9.25News Coverage
Gap Down
COV
Covalon Technologies
0.6$1.55-3.2%C$37.44 millionC$23.84 million-6.51
Emerald Health Therapeutics logo
EMH
Emerald Health Therapeutics
0.5$0.25-2.0%C$34.02 millionC$13.02 million-0.36
IGX
IntelGenx Technologies
0.9$0.53-1.9%C$30.87 millionC$1.54 million-6.54
QPT
Quest PharmaTech
0.8$0.11-4.8%C$21.76 millionC$38,871.000.16Gap Up
CZO
Ceapro
0.7$0.74-1.4%C$21.65 millionC$16.14 million22.42
CTX
Crescita Therapeutics
0.6$0.80-6.3%C$16.52 millionC$15.64 million400.00
KNE
Kane Biotech
0.4$0.19-0.0%C$14.12 millionC$1.34 million-5.43
PAS
Pascal Biosciences
0.6$0.08-6.3%C$12.70 millionN/A-3.64Gap Up
NSP
Naturally Splendid Enterprises
0.6$0.06-0.0%C$11.06 millionC$2.03 million-1.40
MPH
Medicure
0.7$1.63-1.2%C$10.80 millionC$12.71 million-1.05Gap Up
BTI
Bioasis Technologies
0.7$0.34-1.5%C$10.16 millionC$4.12 million30.45Gap Down
HEM
Hemostemix
0.6$0.33-6.2%C$9.07 millionN/A-1.93Gap Down
ICO
iCo Therapeutics
0.5$0.11-0.0%C$7.69 millionN/A-8.75
IBT
IBEX Technologies
0.7$0.38-2.6%C$6.94 millionC$5.60 million7.04
IOT
Innovotech
0.8$0.17-5.9%C$6.52 millionC$1.04 million85.00Gap Down
BCT
BriaCell Therapeutics
0.5$3.61-5.8%C$4.48 millionN/A-1.17
RVV
Revive Therapeutics
0.5$0.08-12.5%C$3.62 millionN/A-3.64High Trading Volume
Gap Down
COT
Cotinga Pharmaceuticals Inc. (COT.V)
0.5$0.04-71.4%C$1.54 millionN/A-0.30Upcoming Earnings
Gap Up
PBS
Pacgen Life Science Co. (PBS.V)
0.6$0.03-16.7%C$1.30 millionC$302,079.00-5.00Gap Down
MFS
Medifocus Inc. (MFS.V)
0.5$0.01-0.0%C$925,000.00C$2.23 million-1.00
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
HALO
Halozyme Therapeutics
1.3$46.51-2.3%C$0.00C$267.59 million51.11
LTY
Liberty Biopharma
0.6$2.00-100.0%C$0.00N/A-12.66Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
SCYB
Scythian Biosciences
0.5$3.49-6.3%C$0.00N/A0.00High Trading Volume
ABCN
VIVO Cannabis
0.6$1.32-5.3%C$0.00N/A0.00News Coverage
Gap Down
VP
Vodis Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.